These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32066273)

  • 1. Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus Statement.
    Eisner BH; Goldfarb DS; Baum MA; Langman CB; Curhan GC; Preminger GM; Lieske JC; Pareek G; Thomas K; Zisman AL; Papagiannopoulos D; Sur RL
    J Endourol; 2020 Nov; 34(11):1103-1110. PubMed ID: 32066273
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological interventions for the management of cystinuria: a systematic review.
    Bhatt NP; Deshpande AV; Starkey MR
    J Nephrol; 2024 Mar; 37(2):293-308. PubMed ID: 37957454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cystinuria].
    Prot-Bertoye C; Daudon M; Tostivint I; Dousseaux MP; Defazio J; Traxer O; Knebelmann B; Courbebaisse M
    Nephrol Ther; 2021 Apr; 17S():S100-S107. PubMed ID: 33910689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystinuria.
    Milliner DS
    Endocrinol Metab Clin North Am; 1990 Dec; 19(4):889-907. PubMed ID: 2081517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-based review of dietary management of cystinuria.
    Ucmak H; Sonmez MG; Guven S
    World J Urol; 2023 May; 41(5):1215-1220. PubMed ID: 36565321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystinuria: clinical practice recommendation.
    Servais A; Thomas K; Dello Strologo L; Sayer JA; Bekri S; Bertholet-Thomas A; Bultitude M; Capolongo G; Cerkauskiene R; Daudon M; Doizi S; Gillion V; Gràcia-Garcia S; Halbritter J; Heidet L; van den Heijkant M; Lemoine S; Knebelmann B; Emma F; Levtchenko E;
    Kidney Int; 2021 Jan; 99(1):48-58. PubMed ID: 32918941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystinuria.
    Mattoo A; Goldfarb DS
    Semin Nephrol; 2008 Mar; 28(2):181-91. PubMed ID: 18359399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on cystinuria in children--the stone management and the prevention of calculi recurrence].
    Asanuma H; Nakai H; Takeda M; Shishido S; Kawamura T; Nagakura K; Yamafuji M
    Nihon Hinyokika Gakkai Zasshi; 1998 Sep; 89(9):758-65. PubMed ID: 9796255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystinuria: an update on pathophysiology, genetics, and clinical management.
    D'Ambrosio V; Capolongo G; Goldfarb D; Gambaro G; Ferraro PM
    Pediatr Nephrol; 2022 Aug; 37(8):1705-1711. PubMed ID: 34812923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability of the medical management of cystinuria.
    Pietrow P; Auge BK; Weizer AZ; Delvecchio FC; Silverstein AD; Mathias B; Albala DM; Preminger GM
    J Urol; 2003 Jan; 169(1):68-70. PubMed ID: 12478105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds.
    Fjellstedt E; Harnevik L; Jeppsson JO; Tiselius HG; Söderkvist P; Denneberg T
    Urol Res; 2003 Dec; 31(6):417-25. PubMed ID: 14586528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staghorn cystine stone in a 72-year-old recurrent calcium stone former.
    Cupisti A; Farnesi I; Armillotta N; Francesca F
    Clin Nephrol; 2012 Jul; 78(1):76-80. PubMed ID: 22732341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Summary of Current Guidelines and Future Directions for Medical Management and Monitoring of Patients with Cystinuria.
    Azer SM; Goldfarb DS
    Healthcare (Basel); 2023 Feb; 11(5):. PubMed ID: 36900678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystinuria: genetic aspects, mouse models, and a new approach to therapy.
    Sahota A; Tischfield JA; Goldfarb DS; Ward MD; Hu L
    Urolithiasis; 2019 Feb; 47(1):57-66. PubMed ID: 30515543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beneficial effect of angiotensin converting enzyme inhibitor treatment in severe cystine urolithiasis].
    Rogowska-Kalisz A; Bilińska W; Nowicki M; Olejniczak D; Chilarski A
    Pol Merkur Lekarski; 2003 Mar; 14(81):253-5. PubMed ID: 12914108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotic syndrome occurring during tiopronin treatment for cystinuria.
    Tasic V; Lozanovski VJ; Ristoska-Bojkovska N; Sahpazova E; Gucev Z
    Eur J Pediatr; 2011 Feb; 170(2):247-9. PubMed ID: 20924604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should patients with cystine stone disease be evaluated and treated in the twenty-first century?
    Andreassen KH; Pedersen KV; Osther SS; Jung HU; Lildal SK; Osther PJ
    Urolithiasis; 2016 Feb; 44(1):65-76. PubMed ID: 26614112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystinuria: definition, epidemiology and clinical aspects.
    Trinchieri A; Dormia G; Montanari E; Zanetti G
    Arch Ital Urol Androl; 2004 Sep; 76(3):129-34. PubMed ID: 15568305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases.
    Cil O; Perwad F
    Pediatrics; 2020 May; 145(5):. PubMed ID: 32245805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cystinuria].
    Dello Strologo L; Laurenzi C; Emma F
    G Ital Nefrol; 2010; 27(1):30-6. PubMed ID: 20191458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.